These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 48829)

  • 21. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 22. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract]   [Full Text] [Related]  

  • 23. Endocrine exophthalmos: an immunologic aberration.
    Kaplan HJ
    Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).
    Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173
    [No Abstract]   [Full Text] [Related]  

  • 25. [Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity].
    Shishiba Y
    Nihon Rinsho; 1978; 36(5):960-6. PubMed ID: 353330
    [No Abstract]   [Full Text] [Related]  

  • 26. Four controversies about the cause of hyperthyroidism.
    Lancet; 1979 Jul; 2(8133):78-80. PubMed ID: 87971
    [No Abstract]   [Full Text] [Related]  

  • 27. [Thyroid-stimulating antibodies].
    Kandror VI; Ibragim MD
    Probl Endokrinol (Mosk); 1985; 31(4):75-80. PubMed ID: 2864686
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Auto-immunity in thyroid disease.
    Chhetri MK; Neelakantan C
    J Indian Med Assoc; 1973 Nov; 61(10):439-40. PubMed ID: 4801912
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogenesis of neonatal Graves' disease.
    McKenzie JM; Zakarija M
    J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
    [No Abstract]   [Full Text] [Related]  

  • 31. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
    Cathelineau G; Fribourg-Desi M
    Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
    [No Abstract]   [Full Text] [Related]  

  • 32. Dysthyroid exophthalmos.
    Fells P
    Br J Radiol; 1972 Nov; 45(539):870. PubMed ID: 4678363
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal antibodies with thyroid stimulating activity, at last.
    Costagliola S; Vassart G
    Thyroid; 2002 Dec; 12(12):1039-41. PubMed ID: 12593716
    [No Abstract]   [Full Text] [Related]  

  • 35. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunologic basis of Graves's disease.
    Volpé R
    N Engl J Med; 1972 Aug; 287(9):463-4. PubMed ID: 5068098
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves' ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith F
    Trans Assoc Am Physicians; 1976; 89():159-70. PubMed ID: 828344
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis and therapy of neonatal graves disease.
    Fisher DA
    Am J Dis Child; 1976 Feb; 130(2):133-4. PubMed ID: 766612
    [No Abstract]   [Full Text] [Related]  

  • 39. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
    Knight J; Laing P; Knight A; Adams D; Ling N
    J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aetiology of hyperthyroidism. II.
    Hoffenberg R
    Br Med J; 1974 Aug; 3(5929):508-10. PubMed ID: 4369764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.